Target Price | $31.25 |
Price | $7.30 |
Potential |
328.08%
register free of charge
|
Number of Estimates | 8 |
8 Analysts have issued a price target Vir Biotechnology Inc 2025 .
The average Vir Biotechnology Inc target price is $31.25.
This is
328.08%
register free of charge
$110.00
1,406.85%
register free of charge
$13.00
78.08%
register free of charge
|
|
A rating was issued by 9 analysts: 6 Analysts recommend Vir Biotechnology Inc to buy, 3 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Vir Biotechnology Inc stock has an average upside potential 2025 of
328.08%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 86.18 | 71.51 |
94.67% | 17.02% | |
EBITDA Margin | -744.43% | -751.95% |
1,517.52% | 1.01% | |
Net Margin | -727.49% | -622.98% |
2,346.96% | 14.37% |
8 Analysts have issued a sales forecast Vir Biotechnology Inc 2024 . The average Vir Biotechnology Inc sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Vir Biotechnology Inc EBITDA forecast 2024. The average Vir Biotechnology Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 Vir Biotechnology Inc Analysts have issued a net profit forecast 2024. The average Vir Biotechnology Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -4.59 | -3.26 |
219.84% | 28.98% | |
P/E | negative | |
EV/Sales | negative |
6 Analysts have issued a Vir Biotechnology Inc forecast for earnings per share. The average Vir Biotechnology Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Vir Biotechnology Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Vir Biotechnology Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.